The Study of the Decade Results are In!


Duke Medicine has found that using a combination of chemicals and UV light to clean patient rooms cut transmission of four major superbugs by a cumulative 30+ percent among a specific group of patients!


Tru-D’s method of measured reflective dose and its impact on infection reduction has been proven!

Enhanced terminal room disinfection strategies that utilized Tru-D SmartUVC reduced the risk of acquisition and infection caused by target multi-drug resistant organisms by greater than 30 percent (Sexton, et al, 2015).

These reduction rates, validated through the first and only randomized clinical trial of its kind, differentiate Tru-D from all other devices on the market.

Read the Abstract

The BETR-D Abstract Presented

The long awaited BETR-D abstract, Benefits of Enhanced Terminal Room Disinfection and a Duke Medicine news article have been released.



See the Latest from Duke